|
14 novembre 2023 |
New tumour markers for pancreatic cancer based on the altered glycosylation of serum glycoproteins |
Duran Sidera, AdriÃ
|
|
setembre 2016 |
Un nou inhibidor sintètic de la sintasa d’à cids grassos (FASN) amb efectes citotòxics |
Polonio Alcalá, Emma
|
|
|
|
Un nou inhibidor sintètic de la sintasa d’à cids grassos (FASN) amb efectes citotòxics |
Polonio Alcalá, Emma
|
|
|
21 juny 2013 |
Nous mecanismes de resistència primà ria al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de cà ncer de mama (Basal/ErbB2+) |
Oliveras Ferrarós, Cristina
|
|
|
|
Nous mecanismes de resistència primà ria al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de cà ncer de mama (Basal/ErbB2+) |
Oliveras Ferrarós, Cristina
|
|
|
2011 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
1 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
|
|
|
5 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
|
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
1 juny 2018 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
|
|
|
5 juny 2018 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
2016 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
2015 |
Obese patients with thyroid cancer: a dangerous surgery? |
Lagarón Manso, Cristina
|
|
|
|
Obese patients with thyroid cancer: a dangerous surgery? |
Lagarón Manso, Cristina
|
|
|
2014 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
1 juny 2018 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
|
|
|
5 juny 2018 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrÃguez Gallego, Esther
; Cufà González, SÃlvia
; Corominas Faja, Bruna
; Cuyà s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
1 juny 2018 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
|
